Skip to main content
. 2007 Sep 19;14(11):1451–1457. doi: 10.1128/CVI.00195-07

TABLE 2.

MenB P1.7-2,4 wild-type isolates investigated in the SBA assay

Isolate Phenotype Immunotype Sequence type Clonal complex Isolation sitea Date of isolation (day/mo/yr) Geographical location
M00 242922 B:4:P1.7-2,4 L1,8 41 41/44 Blood 01/11/2000 London, United Kingdom
M00 243221 B:4:P1.7-2,4 L3,7,9 41 41/44 Blood 13/12/2000 Pinderfield, United Kingdom
M01 240017 B:4:P1.7-2,4 L3,7,9 41 41/44 Blood 31/12/2000 Horton, United Kingdom
M01 240554 B:1:P1.7-2,4 L3,7,9 41 41/44 Blood 26/02/2001 Ipswich, United Kingdom
M01 240566 B:4:P1.7-2,4 L3,7,9 41 41/44 Blood 24/02/2001 Bury St Edmonds, United Kingdom
M01 240805 B:4:P1.7-2,4 L1,8 41 41/44 Blood 15/03/2001 Birmingham, United Kingdom
M01 240938 B:4:P1.7-2,4 L3,7,9 41 41/44 Blood 03/04/2001 London, United Kingdom
M01 241245 B:4:P1.7-2,4 L3,7,9 41 41/44 Blood 10/05/2001 Leeds, United Kingdom
M01 241607 B:4:P1.7-2,4 L3,7,9 41 41/44 Blood 01/07/2001 Camberley, United Kingdom
M01 240149 B:4:P1.7-2,4 L1,8 41 41/44 Blood 12/01/2001 Maidstone, United Kingdom
NZ 98/254 B:4:P1.7-2,4 L1/L3,7,9 42 41/44 CSF 1998 New Zealand
a

CSF, cerebrospinal fluid.